Bionano Genomics, Inc.
BNGO
$3.27
$0.123.81%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 16.44M | 18.23M | 9.48M | 11.95M | 18.94M |
Total Receivables | 3.49M | 3.35M | 4.77M | 5.62M | 6.36M |
Inventory | 8.63M | 9.56M | 11.12M | 14.32M | 19.48M |
Prepaid Expenses | 3.10M | 2.78M | 703.00K | 4.09M | 4.79M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 11.00M | 11.00M | 13.42M | 11.00M | 11.01M |
Total Current Assets | 42.66M | 44.93M | 39.49M | 46.98M | 60.57M |
|
|||||
Total Current Assets | 42.66M | 44.93M | 39.49M | 46.98M | 60.57M |
Net Property, Plant & Equipment | 24.23M | 22.70M | 24.32M | 26.18M | 32.49M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 7.03M | 8.37M | 9.71M | 11.05M | 30.02M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.09M | 2.42M | 3.15M | 3.16M | 6.29M |
Total Assets | 76.01M | 78.41M | 76.67M | 87.36M | 129.36M |
|
|||||
Total Accounts Payable | 6.24M | 6.56M | 6.96M | 8.70M | 8.73M |
Total Accrued Expenses | 2.29M | 2.71M | 4.62M | 4.60M | 3.80M |
Short-term Debt | 11.76M | 13.04M | 20.36M | 14.95M | 19.36M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.60M | 1.85M | 3.25M | 2.22M | 2.41M |
Total Finance Division Other Current Liabilities | 2.28M | 2.25M | 2.15M | 2.47M | 2.87M |
Total Other Current Liabilities | 2.28M | 2.25M | 2.15M | 2.47M | 2.87M |
Total Current Liabilities | 24.18M | 26.41M | 37.34M | 32.95M | 37.18M |
|
|||||
Total Current Liabilities | 24.18M | 26.41M | 37.34M | 32.95M | 37.18M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 11.76M | 13.04M | 20.36M | 14.95M | 19.36M |
Capital Leases | 6.22M | 3.53M | 3.68M | 5.28M | 5.81M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 243.00K | 292.00K | 267.00K | 263.00K | 6.05M |
Total Liabilities | 30.64M | 30.23M | 41.30M | 38.49M | 49.03M |
|
|||||
Common Stock & APIC | 748.57M | 744.50M | 728.57M | 720.43M | 709.19M |
Retained Earnings | -703.18M | -696.33M | -693.23M | -673.10M | -628.85M |
Treasury Stock & Other | -10.00K | 14.00K | 27.00K | 1.53M | -3.00K |
Total Common Equity | 45.37M | 48.19M | 35.38M | 48.87M | 80.34M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 45.37M | 48.19M | 35.38M | 48.87M | 80.34M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 45.37M | 48.19M | 35.38M | 48.87M | 80.34M |
|